Description

Thymalfasin is a synthetic, acetylated 28?amino?acid peptide (thymosin??1), identical to the endogenous human form. It has demonstrated immunomodulatory activity—promoting T?cell maturation, increasing cytokine production (IL?2, IFN??), enhancing NK/dendritic cell function, and acting via TLR?2/9 pathways.‡ It is widely used in research for chronic hepatitis, viral infection models, oncology immunotherapy, sepsis, and vaccine response enhancement.‡

Thymalfasin Injection Product Specifications

Thymalfasin Injection Mechanism of Action

Thymalfasin mimics natural thymosin??1, activating T?cell and NK cell pathways, and modulating cytokine release (IL?2, IL?10, IFN??). It engages Toll?like receptors (TLR?2, TLR?9), enhancing antigen presentation and adaptive immune responses.‡

Thymalfasin Injection Research Applications

• Chronic hepatitis B & C—immunotherapy and viral clearance models

• Cancer immunotherapy—melanoma, HCC, lung, colorectal models

• Sepsis and ARDS—immune regulation in critical illness

• Vaccine adjuvancy—enhanced response in immune-compromised studies

• Immune recovery—post-chemotherapy or immunocompromised models

Safety & Handling

• Lab?grade use only— not for human or veterinary administration

• Handle using standard lab PPE

• Store lyophilized vials at –20?°C; reconstituted material is stable for 2–7?days at 2–8?°C

• Dispose of biological materials according to institutional protocols

Core Keywords

thymalfasin injection, thymosin??1 lyophilized, CAS 62304?98?7, immune modulator peptide, hepatitis B immune therapy, sepsis immune research, cancer immunotherapy agent

Research Use Disclaimer

This product is exclusively for laboratory and preclinical research. It is not approved for diagnostic, therapeutic, clinical, or veterinary use. Misuse may lead to health or regulatory consequences. Use under proper institutional oversight.